Genetic testing through the Precision Peptide panel becomes available for $298, allowing providers to refine therapy based on your unique peptide architecture
Confirmatory diagnostic studies should be performed prior to initiating therapy, if possible, and the patient should be followed with appropriate studies to demonstrate hematologic improvement (Hgb, hematocrit, RBC, reticulocyte count)
Article An average reduction in A1C of 1-1.7% is commonly observed in patients with type 2 diabetes
Some of the most frequent include changes in cost or insurance coverage, unpleasant side effects like nausea, constipation, vomiting or fatigue and the achievement of a targeted weight or health goal
Discontinuation should be discussed with your GP to adjust diabetes management, monitor blood glucose, and prevent complications
This document is a summary of product information and does NOT have all possible information and potential side effects of the product
